Literature DB >> 2144209

Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases.

A R Mackay1, R H Corbitt, J L Hartzler, U P Thorgeirsson.   

Abstract

Current hypotheses suggest that both the plasmin system and metalloproteinases are involved in tumor invasion of basement membrane. In this study, we demonstrate that plasmin can directly degrade native and denatured type IV collagen in solution as well as in tissue sections. Tumor cell lines secreted plasminogen activators into culture supernatants that activated exogenous plasminogen to degrade type IV collagen in zymograms and to remove collagen IV immunoreactivity from tissue sections. Inhibition of metalloproteinase activity in culture supernatants by EDTA did not interfere with plasminogen-mediated type IV collagen degradation. We propose that tumor cells possess a mechanism for the degradation of basement membrane type IV collagen, independent of metalloproteinases but dependent on plasminogen conversion to plasmin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2144209

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  39 in total

1.  Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta.

Authors:  Z Y Hu; Y X Liu; K Liu; S Byrne; T Ny; Q Feng; C D Ockleford
Journal:  J Anat       Date:  1999-02       Impact factor: 2.610

2.  Binding of human plasminogen to basement-membrane (type IV) collagen.

Authors:  M S Stack; T L Moser; S V Pizzo
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

3.  Expression of matrix metalloproteinases in human glioma cell lines in the presence of IL-10.

Authors:  S Wagner; C Stegen; H Bouterfa; C Huettner; S Kerkau; W Roggendorf; K Roosen; J C Tonn
Journal:  J Neurooncol       Date:  1998-11       Impact factor: 4.130

Review 4.  Arterial thrombus formation in cardiovascular disease.

Authors:  Giuseppe Lippi; Massimo Franchini; Giovanni Targher
Journal:  Nat Rev Cardiol       Date:  2011-07-05       Impact factor: 32.419

5.  The influence of antiestrogens on the release of plasminogen activator (uPA) by MDA-MB-231 and MCF-7 breast cancer cells.

Authors:  S M Abidi; E W Howard; J J Dmytryk; J T Pento
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

6.  Different Effects of Lipopolysaccharide on Plasminogen Activator Inhibitor-1 Production in Aortic Media in Vivo and in Culture.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

7.  Plasminogen Deficiency Delays the Onset and Protects from Demyelination and Paralysis in Autoimmune Neuroinflammatory Disease.

Authors:  Maureen A Shaw; Zhen Gao; Kathryn E McElhinney; Sherry Thornton; Matthew J Flick; Adam Lane; Jay L Degen; Jae Kyu Ryu; Katerina Akassoglou; Eric S Mullins
Journal:  J Neurosci       Date:  2017-03-08       Impact factor: 6.167

8.  Alterative expression of the collagenase and adhesion molecules in the highly metastatic clones of human colonic cancer cell lines.

Authors:  Y Nakayama; K Okazaki; K Shibao; T Sako; K Hirata; N Nagata; M Kuwano; H Itoh
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

9.  Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells.

Authors:  T Abe; T Mori; K Kohno; M Seiki; T Hayakawa; H G Welgus; S Hori; M Kuwano
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

Review 10.  Obstructive nephropathy: insights from genetically engineered animals.

Authors:  Jean-Loup Bascands; Joost P Schanstra
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.